Treating muscle wasting with selective androgen receptor modulators

Details for Australian Patent Application No. 2007202324 (hide)

Owner GTx, Inc.

Inventors Dalton, James T; Veverka, Karen A; Miller, Duane D; Steiner, Mitchell S

Agent Griffith Hack

Pub. Number AU-B-2007202324

Parent 2002364949

Filing date 22 May 2007

Wipo publication date 14 June 2007

Acceptance publication date 16 July 2009

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/00 (2006.01)

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/275 (2006.01) - Nitriles

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 21/04 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 39/02 (2006.01) General protective or antinoxious agents

Event Publications

7 June 2007 Complete Application Filed

14 June 2007 Application Open to Public Inspection

  Published as AU-B-2007202324

16 July 2009 Application Accepted

  Published as AU-B-2007202324

12 November 2009 Standard Patent Sealed

18 March 2010 Assignment Registered

  GTx, Inc. The patent has been assigned to University of Tennessee Research Foundation

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007202325-Presbyopia treatment by lens alteration

2007202323-Dual specificity antibodies and methods of making and using